NCT07034183View on ClinicalTrials.gov

A First-in-Human Study of PRD001

PHASE1RecruitingINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

June 19, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Healthy Volunteers
Interventions
DRUG

PRD001

PRD001 capsules will be provided for oral administration

DRUG

Placebo

Placebo capsules will be provided for oral administration

Trial Locations (1)

Unknown

RECRUITING

SOUSEIKAI Fukuoka Mirai Hospital, Fukuoka

Sponsors
All Listed Sponsors
lead

PRD Therapeutics, Inc.

INDUSTRY